🇺🇸 FDA
Pipeline program

Lithium Carbonate 250 MG

2020-27-2

Approved small_molecule completed

Quick answer

Lithium Carbonate 250 MG for Sleep Deprivation is a Approved program (small_molecule) at China SXT Pharmaceuticals with 1 ClinicalTrials.gov record(s).

Program details

Company
China SXT Pharmaceuticals
Indication
Sleep Deprivation
Phase
Approved
Modality
small_molecule
Status
completed

Clinical trials